Geneos Wealth Management Inc. grew its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 11.8% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 19,361 shares of the company's stock after purchasing an additional 2,040 shares during the period. Geneos Wealth Management Inc.'s holdings in Procter & Gamble were worth $3,299,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in the stock. Fortis Capital Advisors LLC bought a new stake in shares of Procter & Gamble during the first quarter worth $276,000. Focus Partners Wealth grew its position in Procter & Gamble by 8.9% in the first quarter. Focus Partners Wealth now owns 1,782,391 shares of the company's stock valued at $303,755,000 after purchasing an additional 145,344 shares in the last quarter. Strive Asset Management LLC grew its position in Procter & Gamble by 3.5% in the first quarter. Strive Asset Management LLC now owns 4,053 shares of the company's stock valued at $691,000 after purchasing an additional 136 shares in the last quarter. Integrity Alliance LLC. grew its position in Procter & Gamble by 229.1% in the first quarter. Integrity Alliance LLC. now owns 42,628 shares of the company's stock valued at $7,265,000 after purchasing an additional 29,676 shares in the last quarter. Finally, Ransom Advisory Ltd bought a new position in Procter & Gamble in the first quarter valued at $3,678,000. Institutional investors own 65.77% of the company's stock.
Analyst Ratings Changes
A number of research firms recently weighed in on PG. Evercore ISI reaffirmed an "in-line" rating and issued a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. BNP Paribas reaffirmed an "outperform" rating and issued a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Barclays set a $164.00 price target on shares of Procter & Gamble and gave the company an "equal weight" rating in a research note on Thursday, July 31st. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, Wells Fargo & Company cut their price target on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $175.12.
Read Our Latest Stock Analysis on PG
Insiders Place Their Bets
In other news, insider Susan Street Whaley sold 1,000 shares of the business's stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $156.84, for a total value of $156,840.00. Following the completion of the transaction, the insider directly owned 28,436 shares in the company, valued at approximately $4,459,902.24. The trade was a 3.40% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jennifer L. Davis sold 8,596 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,351,892.92. Following the completion of the transaction, the chief executive officer owned 64,991 shares of the company's stock, valued at $10,221,134.57. The trade was a 11.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Stock Performance
Shares of NYSE PG traded down $0.61 during mid-day trading on Friday, reaching $158.02. 5,956,120 shares of the company were exchanged, compared to its average volume of 6,033,143. The company's 50-day simple moving average is $156.21 and its 200-day simple moving average is $161.84. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $369.85 billion, a P/E ratio of 24.27, a P/E/G ratio of 4.19 and a beta of 0.36. Procter & Gamble Company has a twelve month low of $149.91 and a twelve month high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. During the same quarter last year, the company posted $1.40 EPS. Procter & Gamble's quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a $1.0568 dividend. The ex-dividend date was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble's payout ratio is 64.98%.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report